🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

📢Calling #GastroTwitter!! Join us for #PBC Week with @GIJournal and @KowdleyMd, Raj VuppaLanchi, & Sonal Kumar, MD MPH 🎥Broadcasts June 26, 2023 @ 2:30PM ET June 28, 2023 @ 2:30PM ET 🧵Medical Minutes Threads June 27, 2023 June 29, 2023 ℹ️CME Info: iridiumce.com/pbc

If you are wondering about the future of NAFLD/MASLD the The Lancet has published data showing that 1.31 Billion People could be living with T2DM by 2050!! #LiverTwitter Naim Alkhouri Maru Rinella MD AASLD American Gastroenterological Association (AGA) W Ray Kim Cheng Han Ng pubmed.ncbi.nlm.nih.gov/37356446/

🆓 #CME Broadcast w/Iridium Continuing Education & GI Journal Club - 👋 @KowdleyMd Sonal Kumar, MD MPH & Raj VuppaLanchi - 🗣️#PBC patho and s/sx - CME ℹ️: iridiumce.com/pbcbroadcastone - Supported by an independent educational grant from Intercept Pharma x.com/i/broadcasts/1…

Couldn’t agree more!

How does diabetes influence outcomes in NAFLD? ▶️>2000 participants with NAFLD characterized by MR elastography DM a/w ⬆️risk of decompensation and #HCC ❗️Independent of baseline liver stiffness New data @_NAFLDResearch Rohit Loomba The Lancet Gastroenterology & Hepatology thelancet.com/journals/langa…

Intermittent fasting and the liver Open access: journals.lww.com/hepcomm/Fullte… Dr. Tatyana Kushner Sonal Kumar, MD MPH in Hepatology Communications

What is the role of #IntermittentFasting in #MASLD Tackled this❓in our review and meta-analysis Dr. Tatyana Kushner Sonal Kumar 👉🏻 14 studies, 840 pts 👉🏻 ➕in body wt, BMI, waist-to-hip 👉🏻 ➕in AST/ALT, liver steatosis/stiffness Hepatology Communications pubmed.ncbi.nlm.nih.gov/37534936/

Sign up for our interactive #CME symposium on #MASLD and #MASH: Saturday, November 11, 2023, at 7:30pm at Boston Marriott Copley Place. Including “What Would You Do?” Challenge yourself to make clinical decisions for the management of MASLD/MASH! #TLM23 liver.imne.com

Targeting the Metabolic Mechanisms of Disease: Are We Getting Closer? Sonal Kumar, MD MPH shares lots of insights tonight at #tlm23 AASLD - projections 2015-2030 more prevalent in advanced liver disease group MASLD and CVD are: • Manifestations of end-organ damage in

Not all Apps are Created Equally! Naim Alkhouri and Sonal Kumar lead a great discussion today at #tlm23 AASLD. Dr. Alkouri shared: Three tiers: - NOOM. Available online for patient support. - Aspyre Rx. Through insurance. “The next frontier in digital therapeutics.”

So happy for my dear friend Jeffrey V. Lazarus for winning this prestigious award from the American Liver FDN . AASLD Foundation Alina Allen Aleksander Krag Mazen Noureddin, MD, MHSc Rohit Kohli, MBBS, MSCI, FAASLD, NASPGHAN-F Juan Pablo (JP) Arab, MD  Sonal Kumar, MD MPH EASL Education Arizona Liver Health

Thanks for a great discussion FattyLiverAlliance

“It’s not what you do, it’s how you make people feel” So lucky to have Mark B. Pochapin, MD speak at Weill Cornell Medicine GI & Hepatology Grand Rounds during colon cancer awareness month

Thank you to Sonal Kumar, MD MPH, Mazen Noureddin, MD, MHSc, Supriya Joshi, MD, Jonathan G. Stine, MD MSc, FACP, Nadege Gunn, Manal Abdelmalek, Naim Alkhouri, Maru Rinella MD, Jörn Schattenberg , Shira zelber sagi and Jeffrey V. Lazarus for generously spending time with Michael Betel and FattyLiverAlliance creating this series of 10 patient focused

#DDW2024 💡 Join us in room 202B to hear about #multidisciplinary management of #MASLD #obesity Sonal Kumar, MD MPH with an excellent talk on new #GLP-1 #ozempic in MASLD. I am next: #Endobariatrics!

Brett E Fortune MD Sonal Kumar, MD MPH Marina Serper, MD, MS first successful meeting of the ILS consortium in the books! Thanks for the great input.

Proud of my friend Alina Allen for presenting the MASLD debrief. Exciting data on genetics/ phenotyping/ GLP1 RAs/ and of course new therapeutics:)) Luis Antonio Díaz, MD Elliot Tapper Mazen Noureddin, MD, MHSc Sonal Kumar, MD MPH Madrigal Pharmaceuticals akerotx Arizona Liver Health FattyLiverAlliance

We are so excited to have you!

PBC patients are highly informed, and Sonal Kumar, MD MPH credits their active participation in their own care! They don't like one size fits all, and have embraced more tailored risk assessments, treatments goals, and management. Learn the latest for PBC! ➡️ ms.spr.ly/6014qGVYp

Key learning point from Sonal Kumar, MD MPH Weill Cornell Medicine #hepatology #livertwitter at #CCOM2025 👉Liver enzymes do not matter 👉Normal enzyme levels could have cirrhosis 👉Elevated enzyme levels could have no fibrosis